Reduced RBM3 expression is associated with aggressive tumor features in esophageal cancer but not significantly linked to patient outcome.

Katharina GruppBianca HofmannAsad KutupKai BachmannDean BogoevskiNathaniel MellingFaik Guntac UzunogluAlexander Tarek El GammalChristina KoopRonald SimonStefan SteurerTill KrechSusanne Burdak-RothkammFrank JacobsenGuido SauterJakob IzbickiWaldemar Wilczak

Published in: BMC cancer (2018)

In summary, the present study shows that decreased RBM3 expression is associated with unfavourable esophageal cancer phenotype, but not significantly linked to patient prognosis.

Keyphrases

poor prognosis
case report
binding protein